NCT02673996View on ClinicalTrials.gov

POTS Adrenergic Ab (CIHR Aims #1&2)

RecruitingOBSERVATIONAL
Enrollment

125

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2027

Conditions
Postural Tachycardia Syndrome
Interventions
DRUG

Phenylephrine

incremental small doses of IV phenylephrine to find the dose that transiently raises systolic blood pressure by 25 mmHg

DRUG

Isoproterenol

incremental small doses of IV isoproterenol to find the dose that transiently raises heart rate by 25 bpm

Trial Locations (1)

T2N 4Z6

RECRUITING

University of Calgary, Calgary

All Listed Sponsors
lead

University of Calgary

OTHER